Company Description

Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation biologics for severe immunological and inflammatory diseases. Bionyra’s best-in-class mono and multispecific antibodies with half-life extension technology target novel immune pathways, enabling deeper and more durable disease control, with an initial focus on atopic dermatitis and inflammatory bowel disease.